- Motley Fool•6 days ago
The costs of these drugs are astronomical -- from $543,000 per year to more than $1 million per year.
- Investor's Business Daily•11 days ago
Depomed and Horizon Pharma could rock the drug sector after reporting first-quarter earnings, an analyst said Wednesday.
- GlobeNewswire•11 days ago
DUBLIN, Ireland, April 13, 2017-- Horizon Pharma plc, a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible ...
HZNP: Summary for Horizon Pharma plc - Yahoo Finance
Horizon Pharma Public Limited Company (HZNP)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
|Bid||14.78 x 600|
|Ask||15.38 x 600|
|Day's range||14.84 - 15.24|
|52-week range||13.05 - 23.44|
Trade prices are not sourced from all markets
|PE ratio (TTM)||-14.41|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|